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Abstract
Introduction: Calcitonin is a very sensitive marker of medullary thyroid carcinoma (MTC). High concentrations of basal or pentagastrin
stimulated calcitonin in patients with MTC is a signal of recurrence or metastatic disease. Detection of metastatic foci remains a diagnostic
and therapeutic challenge.
The aim of the study was to present examples of the use of 68Ga-DOTA-TATE PET-CT examinations in the diagnosis of patients with MTC
and concomitant elevated serum calcitonin concentrations.
Initially the study involved eight patients with MTC and elevated basal or stimulated calcitonin, in which earlier diagnostic imaging was
negative for metastasis: neck ultrasound, chest and mediastinal CT scan, liver MRI, bone scintigraphy, and 18F-FDG-PET. A total body scan
was performed using 68Ga-DOTA-TATE PET-CT. Two patients with positive diagnostic imaging tests were referred for surgery including
resection of cervical lymph nodes with histopathological examination for assessment of metastases.
Conclusions: On the basis of the presented cases we conclude that PET-CT scan with somatostatin analogue labelled with gallium (68Ga-
-DOTA-TATE PET-CT) may be useful in the diagnostic imaging of patients with disseminated MTC.
(Pol J Endocrinol 2010; 61 (5): 507–511)
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Streszczenie
Wstęp: Kalcytonina jest bardzo czułym markerem rdzeniastego raka tarczycy (MTC, medullary thyroid carcinoma). Wysokie stężenie kalcy-
toniny podstawowej lub stymulowanej pentagastryną u pacjentów z MTC świadczy o wznowie lub obecności zmian przerzutowych.
Poszukiwanie tych ognisk stanowi istotny problem diagnostyczno-kliniczny.
Celem pracy było przedstawienie możliwości wykorzystania badań 68Ga-DOTA-TATE PET-CT w diagnostyce pacjentów z MTC i współ-
istniejącym podwyższonym stężeniem kalcytoniny w surowicy.
Wyjściowo badaniem objęto 8 chorych z MTC i podwyższonym stężeniem kalcytoniny podstawowej lub stymulowanej, u których
w dotychczasowych badaniach obrazowych (USG szyi, CT klatki piersiowej i śródpiersia, MRI wątroby, scyntygrafia kośćca oraz 18F-FDG
PET) nie uwidoczniono ognisk przerzutowych.
U wszystkich chorych wykonano badanie całego ciała z zastosowaniem analogu somatostatyny znakowanego galem 68. Chorych z dodat-
nim wynikiem badania zakwalifikowano do leczenia operacyjnego. Oceniono wyniki badania histopatologicznego.
U 2 spośród 8 pacjentów z rozpoznaniem MTC oraz z podwyższonym stężeniem kalcytoniny stwierdzono dodatni wynik scyntygrafii
68Ga-DOTA-TATE PET-CT. Chorych skierowano do leczenia operacyjnego obejmującego wycięcie węzłów chłonnych szyi.
Wyniki badania histopatologicznego potwierdziły obecność przerzutów w wyciętych węzłach chłonnych.
Wnioski: Prezentowane przypadki sugerują, że badanie PET z analogiem somatostatyny znakowanym galem 68 (68Ga-DOTA-TATE PET-CT)
jest przydatne w diagnostyce obrazowej chorych z MTC. Pozwoliło ono na lokalizację ognisk przerzutowych u 2 spośród 8 pacjentów.
(Endokrynol Pol 2010; 61 (5): 507–511)
Słowa kluczowe: rak rdzeniasty tarczycy, 68Ga-DOTA-TATE, pozytronowa tomografia emisyjna, kalcytonina, przerzuty nowotworowe
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Introduction
Medullary thyroid carcinoma (MTC) is a rare neoplasm
which makes up from 5% to 10% of all thyroid cancers.
It is characterized by an early metastasis to the cervical
lymph nodes encompassing 50–75% of all cases. In ini-
tial diagnosis (preoperative), distant metastasis is con-
firmed in 10–15% of all patients. They are located most
frequently in the mediastinum, lungs, liver, and bone,
and less frequently in the brain and skin [1].
Calcitonin concentration in serum forms the most
sensitive hormonal preoperative marker for MTC, mon-
itoring effectiveness of treatment, and for detecting re-
currence of disease [2].
Proper staging of primary MTC and early detection
of recurrence or spread of neoplasm form the basis for
the appropriate treatment scheme (decision on opera-
tion, scope of operation, and implementation of pallia-
tive care).
Due to the difficulty of imaging, various available
diagnostic tests are employed. Among morphological
imaging methods ultrasound and CT of the neck are
used to search for lesions in the neck, chest CT to search
for lung and mediastinal metastasis, and ultrasound and
MRI of the liver to assess liver lesions [3]. Bone scintig-
raphy, used to evaluate the entire skeletal system, is also
well established in the diagnostic algorithm of suspect-
ed MTC dissemination.
Other traditional nuclear medicine tests include pla-
nar imagining and SPECT using oncophilic radiophar-
maceuticals (99mTc-(V)-DMSA, 131I-MIBG, 99mTc-SESTA-
MIBI, isotope-labelled anti-CEA and anti-calcitonin an-
tibodies) and receptor imaging (somatostatin analogues
labelled with technetium 99mTc or indium 111In) [4, 5].
Nevertheless, classic nuclear medicine tests (both
planar and SPECT) are characterized by low sensitivity
due to low resolution and lack of reference to anatom-
ical structures.
It was not until development of the PET scan and
then the PET-CT that the resolution improved and re-
sulted in better detection of neoplastic lesions. 18F-FDG
— fluorodeoxyglucose is the most commonly used ra-
diopharmaceutical used in PET scans, which serves to
detect elevated glucose metabolism in neoplastic cells.
18F-DOPA is an amine precursor taken up by neuroen-
docrine cells. Radiopharmaceuticals for imaging of so-
matostatin receptors (i.e. 68Ga-DOTA-TATE) constitute
an alternative option.
Goal
The aim of the study was to present the usefulness of
PET-CT examinations with somatostatin analogue la-
belled with gallium-68 (68Ga-DOTA-TATE PET-CT) in
patients with MTC and elevated calcitonin concentra-
tions, in whom previously performed imaging did not
detect metastatic foci or local recurrence.
Material
The study initially compassed 8 patients with MTC
(4 men and 4 women between 41 and 72 years of age,
mean 55.6 years). The period of observation was from
1 to 7 years (mean: 3.6). In every patient an elevated
basal and/or stimulated calcitonin concentration was ev-
idence of persistent neoplastic disease. At the time of
68Ga-DOTATATE PET-CT testing, the basal serum concen-
tration of calcitonin in 5 patients was below 100 pg/ml,
and in the others: 155 pg/ml, 500 pg/ml, 461pg/ml, and
720 pg/ml (mean 265pg/ml).
Before performing the 68Ga-DOTA-TATE PET-CT
examination no foci of metastasis were visualized in any
patient with imaging done to that point: ultrasound of
neck, CT of chest and mediastinum, MRI of liver, bone
scintigraphy, and 18F-FDG PET.
The patient characteristics are shown in Table I. Cal-
citonin concentrations during observation are shown
in Figure 1.
Method
A whole body scan using a gallium-labelled somatosta-
tin analogue 68Ga-DOTA-TATE PET-CT was per-
formed. 68Ga DOTA-TATE was prepared in the Nucle-
ar Medicine Department of SOC. 68Ga eluate was ob-
tained from a generator of 68Ge/68Ga (manufactured by
IDB Holland BV). DOTATATE was provided by IAE
Radioisotope Centre POLATOM, Otwock-Swierk. PET-
CT scans were performed using hybrid camera Biograph
64 Siemens, 60 minutes after intravenous administra-
tion of 68Ga DOTA-TATE with an activity of 120–185
MBq. Acquisition time of PET was 3 min./bed. Exami-
nation range was from the top of the skull cap to
1/3 proximal femur. CT scan was performed with the
aim of localizing changes and carrying out correction
of attenuation (acquisition parameters: 120 kV, 35 mA,
4 s, slice thickness 2 mm).
Patients with a positive test were referred for surgi-
cal treatment.
Results
In 2 of 8 patients diagnosed with MTC and elevated
calcitonin concentration, positive results of scintigraphy
using 68Ga-DOTA-TATE PET-CT were shown. These
were: a woman G Z and a man W W with initial serum
calcitonin concentrations of 720 pg/mL and 500 pg/mL,
respectively. Both patients showed pathological radio-
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pharmaceutical accumulation in the neck lymph nodes.
Patient W W showed foci of pathological accumulation
in right upper paratracheal lymph node and anterior
mediastinal lymph node, patient G Z within in the left
upper cervical lymph node and the left supraclavicular
lymph node. A noteworthy fact is that in the initial post-
operative assessment, despite excision of 30 lymph
nodes (central compartment of the neck and right lat-
eral side at the location of the tumour on the right side),
no metastasis to the lymph nodes was discovered in
the patient. Seven years later, lesions in lymph nodes
were discovered on the left side.
Patients were referred for surgical treatment by
modified dissection of lateral neck lymph nodes. His-
Table 1. Clinical characteristics of examined patients
Tabela 1. Charakterystyka kliniczna badanych pacjentów
Patient Gender Age when examined Stage of advancement Time since Initial calcitonin
(years)  pTNM operation  concentration
(years)  at examination [pg/ml]
GS M 72 pT3Nx 4 66
SB K 56 pT1Nx (12 mm) 3 53
LB K 41 pT3N1a 1 76
WW M 61 pT3N2b 1 500
PE K 45 pT2Nx 13 155
GZ K 58 pT2No 7 720
ZZ M 53 pTxN1 3 461
BP M 59 pTxN1 3 89
Figure 1. Primary and stimulated calcitonin concentrations in the patient study group
Rycina 1. Podstawowe i stymulowane stężenia kalcytoniny w badanej grupie
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topathological examination confirmed the presence of
metastatic medullary thyroid carcinoma (MTC) in the
excised lymph nodes.
Discussion
The prognosis of MTC is intermediate between differ-
entiated thyroid cancers and anaplastic cancer. Nega-
tive prognostic factors in MTC are: age, male gender,
high preoperative calcitonin concentration, tumour size
>4 cm, occupation of lymph nodes, vascular invasion,
presence of “macroscopic disease”, and distant metasta-
sis. Based on multivariate analysis, the most important
survival prognostic factors are disease advancement and
age of the patient at diagnosis [6–11].
In accordance with the recommendations of the
American Thyroid Association (ATA), a calcitonin con-
centration of >150 pg/mL is believed to be “significant-
ly elevated”, above which imaging is recommended
with the aim of searching for metastasis. A similar pro-
cedure should follow if the increase of calcitonin con-
centration is 20–100% in subsequent control examina-
tions [3, 12]. This was confirmed in our study as we were
able to visualize cancer foci only in two patients with
Figure 2 A. 68Ga-DOTA-TATE PET-CT — patient WW; pathological accumulation in the right upper paratracheal lymph node and
anterior mediastinal lymph node; B. 68Ga-DOTA-TATE PET-CT — patient GZ; pathological accumulation in the left upper cervical
lymph node and the left supraclavicular lymph node.
Rycina 2 A. 68Ga-DOTA-TATE PET-CT — pacjent WW; ogniska patologicznego gromadzenia w węzłach chłonnych przytchawiczym
po stronie prawej i w śródpiersiu przednim; B. 68Ga-DOTA-TATE PET-CT — pacjent GZ; ogniska patologicznego gromadzenia
w obrębie węzła chłonnego szyjnego górnego po stronie lewej i nadobojczykowego po stronie lewej
the highest calcitonin level. Searching for foci of me-
tastasis is an important diagnostic-clinical problem. The
chance of cure is increased with early visualization of
local recurrence or metastases and their effective surgi-
cal treatment. MTC as a neuroendocrine cancer may
have somatostatin receptors on the surface of their cells.
In-vitro studies on MTC cells with the help of RT-PCR
identified two subtypes of somatostatin receptors:
(SSTR)- type 2 (SSTR2) and type 5 (SSTR5). However,
immunohistochemical examination showed a low den-
sity of these receptors on the cell surface of MTC cells
[13]. Tumours that have SSTR on their surface can be
diagnosed by using somatostatin analog radioisotopes
labelled with indium (111In) or technetium (99mTc) in
SPECT tests or in PET scans using DOTA-TOC, DOTA-
TATE, DOTA-NOC.
In our study we utilized a new radiopharmaceuti-
cal — 68Ga-DOTA-TATE. This compound consists of so-
matostatin analog (DOTA-TATE) labelled with gallium
68, a PET generated isotope with a half life of 68 min.
68Ga-DOTA-TATE shows an affinity to type 2 receptor.
It is characterized by a good tumour/background ratio.
The main limitation of using 68Ga-DOTA-TATE is that
only 40% of cells express somatostatin receptors on their
A
B
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surface. The image of small metastases to the liver us-
ing 68Ga-DOTA-TATE is usually negative. For this pur-
pose 18F-FDG is used but is effective only in large me-
tastases [14].
Conclusions
On the basis of the presented cases we conclude that
PET-CT scans with somatostatin analogue labelled with
gallium (68Ga-DOTA-TATE PET-CT) may be useful in
the diagnostic imaging of patients with disseminated
MTC.
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